Application of Both Cluster and Principal Component Analysis for Evaluation of the Lipophilicity Parameters of Selected Antiandrogen Drugs †
Abstract
:Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wardecki, D.; Dołowy, M.; Bober-Majnusz, K. Application of Both Cluster and Principal Component Analysis for Evaluation of the Lipophilicity Parameters of Selected Antiandrogen Drugs. Med. Sci. Forum 2022, 14, 18. https://doi.org/10.3390/ECMC2022-13262
Wardecki D, Dołowy M, Bober-Majnusz K. Application of Both Cluster and Principal Component Analysis for Evaluation of the Lipophilicity Parameters of Selected Antiandrogen Drugs. Medical Sciences Forum. 2022; 14(1):18. https://doi.org/10.3390/ECMC2022-13262
Chicago/Turabian StyleWardecki, Dawid, Małgorzata Dołowy, and Katarzyna Bober-Majnusz. 2022. "Application of Both Cluster and Principal Component Analysis for Evaluation of the Lipophilicity Parameters of Selected Antiandrogen Drugs" Medical Sciences Forum 14, no. 1: 18. https://doi.org/10.3390/ECMC2022-13262
APA StyleWardecki, D., Dołowy, M., & Bober-Majnusz, K. (2022). Application of Both Cluster and Principal Component Analysis for Evaluation of the Lipophilicity Parameters of Selected Antiandrogen Drugs. Medical Sciences Forum, 14(1), 18. https://doi.org/10.3390/ECMC2022-13262